Avalon GloboCare (ALBT) - Aggregate Business Assets

Official company branding of Avalon GloboCare Corp. (ALBT)

The clinical base and diagnostic capacities of Avalon GloboCare (ALBT) operate at constant capacity, which is confirmed by the daily price chart of total assets at 23.19. The business relies on regular laboratory research and the development of regenerative medicine, ensuring a steady cash flow. The integration of scientific research into practical treatment through a unified network of centers transforms the company into a key element of modern healthcare.

ALBT (avalon-globocare.com) Company Total Assets history from 04/28/2023 to 07/22/2026

Comprehensive metric breakdowns and analytics for avalon-globocare.com (ALBT)

- share price and expert price forecast:
Price Avalon GloboCare Corp.|ALBT - Consensus Target
- market capitalization indicators:
Market Value Avalon GloboCare|ALBT - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Avalon GloboCare|ALBT - Book Capitalization|Market-to-Book Ratio avalon-globocare.com|ALBT - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Avalon GloboCare|ALBT - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Avalon GloboCare Corp.|ALBT - Company Debts|Debt to Book Value Avalon GloboCare|ALBT - Company Long-Term Debts|Short-Term Debt Avalon GloboCare|Immediate Liquidity Ratio avalon-globocare.com
- net income and valuation multiples indicators:
ALBT - Net Income
Basic company analysis:ALBT, Avalon GloboCare Corporation
Manufactured product of Avalon GloboCare

Total assets, reverse-calculated via ROA, reflect the aggregate volume of the company's resources, allowing for a comparison between market capitalization and the business's actual material base. By analyzing the total asset value, an investor can assess the stability of Avalon GloboCare (ALBT), where the capitalization of laboratories and clinical research infrastructure create a defensive barrier against competitors and support the fundamental value of the assets.

Direct competitors

HCA: Aggregate Business Assets|Cumulative Company Assets THC|FMS (Fresenius Medical Care AG) - Aggregate Business Assets|Aggregate Company Assets Solventum Inc. (SOLV)|EHC (Encompass) - Aggregate Asset Value|Company Total Assets UHS (Universal Health Services, Inc.)|davita.com (DVA) - Company Assets|RadNet - Company Total Assets|OPCH - Company Total Assets|SGRY (Surgery Partners Corp) - Cumulative Company Assets|PINC: Aggregate Business Assets|Aggregate Company Assets National Vision Holdings|Cumulative Company Assets progyny.com (PGNY)|Company Total Assets ARDT|SEM - Company Assets|Aggregate Company Assets Apollo Medical Holdings ASTH|MD: Total Business Assets|USPH: Cumulative Company Assets|pennantgroup.com - Aggregate Business Assets|ORGO: Company Total Assets|Nutex Health Inc (NUTX) - Company Total Assets|Cumulative Company Assets AUNA|Aggregate Company Assets SBC|Company Total Assets EOLS|Company Total Assets chs.net (CYH)|Aggregate Company Assets BeautyHealth SKIN|MediWound Ltd - Aggregate Company Assets|BTMD - Aggregate Company Assets|Company Assets The Joint|DocGo Inc. (DCGO) - Aggregate Company Assets|Total Business Assets PIII|Cumulative Company Assets GANX|EUDA: Aggregate Asset Value|Company Total Assets BMGL|collplant.com (CLGN) - Company Balance Sheet Assets|Aggregate Company Assets Cuprina Holdings (Cayman) Ltd CUPR|concordmedical.com - Aggregate Company Assets|AMS - Aggregate Company Assets|Company Assets MEDIROM Healthcare Group Inc.|DHAI: Company Total Assets|XAGE (Carmell Corp) - Aggregate Company Assets|Aggregate Company Assets NewGenIvf Group Limited|Company Assets ATI Physical Therapy Corp ATIP|Company Total Assets CMAX|Cumulative Company Assets Kindly MD Inc KDLY|Company Total Assets MODV (LogistiCare)|Company Total Assets Novo Integrated Sciences Corp NVOS|SSY - Aggregate Company Assets|Aggregate Asset Value BACK (imacholdings.comm)